Angiosarcoma of the Scalp Presenting in Association With Borderline Malignant Phyllodes Tumour of the Breast

由 Harden, Susan V., Ball, Richard Y., Harnett, Adrian N.
出版 2003

Standards of care in mesothelioma treatment

由 Harden, Susan V., Darlison, Liz, Beckett, Paul, Bibby, Anna C.
發表在 Br J Cancer (2020)

Apples and pears? A comparison of two sources of national lung cancer audit data in England

由 Khakwani, Aamir, Jack, Ruth H., Vernon, Sally, Dickinson, Rosie, Wood, Natasha, Harden, Susan, Beckett, Paul, Woolhouse, Ian, Hubbard, Richard B.
發表在 ERJ Open Res (2017)

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury

由 Doherty, Gary Joseph, Duckworth, Adam M, Davies, Susan E, Mells, George F, Brais, Rebecca, Harden, Susan V, Parkinson, Christine A, Corrie, Pippa G
發表在 ESMO Open (2017)

Quantitative and textural analysis of magnetization transfer and diffusion images in the early detection of brain metastases

由 Ainsworth, Nicola L., McLean, Mary A., McIntyre, Dominick J.O., Honess, Davina J., Brown, Anna M., Harden, Susan V, Griffiths, John R.
發表在 Magn Reson Med (2016)

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

由 Seckl, Michael J., Ottensmeier, Christian H., Cullen, Michael, Schmid, Peter, Ngai, Yenting, Muthukumar, Dakshinamoorthy, Thompson, Joyce, Harden, Susan, Middleton, Gary, Fife, Kate M., Crosse, Barbara, Taylor, Paul, Nash, Stephen, Hackshaw, Allan
發表在 J Clin Oncol (2017)

(18)F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

由 Manoharan, Prakash, Salem, Ahmed, Mistry, Hitesh, Gornall, Michael, Harden, Susan, Julyan, Peter, Locke, Imogen, McAleese, Jonathan, McMenemin, Rhona, Mohammed, Nazia, Snee, Michael, Woods, Sarah, Westwood, Thomas, Faivre-Finn, Corinne
發表在 J Thorac Oncol (2019)

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study

由 Haslett, Kate, Bayman, Neil, Franks, Kevin, Groom, Nicki, Harden, Susan V., Harris, Catherine, Hanna, Gerard, Harrow, Stephen, Hatton, Matthew, McCloskey, Paula, McDonald, Fiona, Ryder, W. David, Faivre-Finn, Corinne
發表在 Int J Radiat Oncol Biol Phys (2021)

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with...

由 Conibear, John, Chia, Brendan, Ngai, Yenting, Bates, Andrew Tom, Counsell, Nicholas, Patel, Rushil, Eaton, David, Faivre-Finn, Corinne, Fenwick, John, Forster, Martin, Hanna, Gerard G, Harden, Susan, Mayles, Philip, Moinuddin, Syed, Landau, David
發表在 BMJ Open (2018)

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

由 Haslett, Kate, Franks, Kevin, Hanna, Gerard G, Harden, Susan, Hatton, Matthew, Harrow, Stephen, McDonald, Fiona, Ashcroft, Linda, Falk, Sally, Groom, Nicki, Harris, Catherine, McCloskey, Paula, Whitehurst, Philip, Bayman, Neil, Faivre-Finn, Corinne
發表在 BMJ Open (2016)

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

由 Faivre-Finn, Corinne, Snee, Michael, Ashcroft, Linda, Appel, Wiebke, Barlesi, Fabrice, Bhatnagar, Adityanarayan, Bezjak, Andrea, Cardenal, Felipe, Fournel, Pierre, Harden, Susan, Le Pechoux, Cecile, McMenemin, Rhona, Mohammed, Nazia, O'Brien, Mary, Pantarotto, Jason, Surmont, Veerle, Van Meerbeeck, Jan P, Woll, Penella J, Lorigan, Paul, Blackhall, Fiona
發表在 Lancet Oncol (2017)

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

由 Fenwick, John D., Landau, David B., Baker, Angela T., Bates, Andrew T., Eswar, Chinnamani, Garcia-Alonso, Angel, Harden, Susan V., Illsley, Marianne C., Laurence, Virginia, Malik, Zafar, Mayles, William Philip M., Miles, Elizabeth, Mohammed, Nazia, Spicer, James, Wells, Paula, Vivekanandan, Sindu, Mullin, Anne-Marie, Hughes, Laura, Farrelly, Laura, Ngai, Yenting, Counsell, Nicholas
發表在 Int J Radiat Oncol Biol Phys (2020)

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

由 Landau, David B., Hughes, Laura, Baker, Angela, Bates, Andrew T., Bayne, Michael C., Counsell, Nicholas, Garcia-Alonso, Angel, Harden, Susan V., Hicks, Jonathan D., Hughes, Simon R., Illsley, Marianne C., Khan, Iftekhar, Laurence, Virginia, Malik, Zafar, Mayles, Helen, Mayles, William Philip M., Miles, Elizabeth, Mohammed, Nazia, Ngai, Yenting, Parsons, Emma, Spicer, James, Wells, Paula, Wilkinson, Dean, Fenwick, John D.
發表在 Int J Radiat Oncol Biol Phys (2016)